Capital CS Group, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital CS Group, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$146,509
-66.3%
17,5250.0%0.17%
-60.0%
Q2 2023$435,321
+65.2%
17,5250.0%0.43%
+73.9%
Q1 2023$263,576
+27.1%
17,5250.0%0.25%
+8.7%
Q4 2022$207,321
+99.3%
17,5250.0%0.23%
+104.5%
Q3 2022$104,000
+40.5%
17,5250.0%0.11%
+45.5%
Q2 2022$74,000
-55.7%
17,5250.0%0.08%
-46.9%
Q1 2022$167,000
-60.5%
17,525
-21.1%
0.14%
-56.3%
Q4 2021$423,000
-34.7%
22,2250.0%0.33%
-44.8%
Q3 2021$648,00022,2250.60%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders